Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss

Articles From: 3M Scientist Receives Lifetime Achievement Award for Hearing Conservation to 3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012

This site contains about 63,386 documents.
View by:
Title  |  Date  |  Author  |  Collection  |  Interest  |  Popularity
Page:   1   1,100   1,200   1,300   1,400   1,500   1,600   1,700   1,800   1,900   2,010   2,020   2,030   2,040   2,050   2,060   2,070   2,080   2,083   2,084   2,085   2,086   2,087   2,088   2,089   2,090   2,091   2,092   2,093   2,094   2,095   2,096   2,097   2,098   2,099   2,100   2,101   2,102   2,103   2,104   2,105   2,106   2,107   2,108   2,109   2,110   2,111   2,112   2,113 

2013/2/4
3M Scientist Receives Lifetime Achievement Award for Hearing Conservation
Elliott Berger, M.S., Division Scientist for 3M’s Personal Safety Division, will be presented with the National Hearing Conservation Association (NHCA) Lifetime Achievement Award in St.
View more 3M Scientist Receives Lifetime Achievement Award for Hearing Conservation analysis
Sign-up for 3M Scientist Receives Lifetime Achievement Award for Hearing Conservation investment picks
2013/2/21
3M Showcases Large-format Multi-touch Capabilities at Digital Signage Expo 2013
As an innovation leader in projected capacitive (PCAP) touchscreen technology and electronics, 3M Touch Systems, a wholly-owned subsidiary of 3M Company, will be showcasing its multi-touch expertise at Digital Signage Expo 2013 (February 27-28 in Las Vegas). 3M will be featuring two “must see” large-format multi-touch display prototypes that include an 84-inch collaboration table concept and a 55-inch interactive digital wall display, featuring a remarkable 40 simultaneous touch points.
View more 3M Showcases Large-format Multi-touch Capabilities at Digital Signage Expo 2013 analysis
Sign-up for 3M Showcases Large-format Multi-touch Capabilities at Digital Signage Expo 2013 investment picks
2013/3/4
3M Teams With AORN, IAHCSMM, SIS and Practice Greenhealth to Ignite OneTogether Movement
3M Infection Prevention and founding partners, Association of periOperative Registered Nurses (AORN), International Association of Healthcare Central Service Materiel Management (IAHCSMM), the Surgical Infection Society (SIS), and Practice Greenhealth have joined together to form OneTogether: The Power of Small Actions , a multi-year program with the goal of driving individual small actions to collectively generate a significant impact on the incidence of healthcare-associated infections (HAIs). The OneTogether program is designed to amplify individual actions, support collaborative opportunities and engage a network of professionals working toward the same goal.
View more 3M Teams With AORN, IAHCSMM, SIS and Practice Greenhealth to Ignite OneTogether Movement analysis
Sign-up for 3M Teams With AORN, IAHCSMM, SIS and Practice Greenhealth to Ignite OneTogether Movement investment picks
2013/2/19
3M to Participate in Upcoming Investor Conference
3M (NYSE: MMM) today announced that it will participate in the Barclays Industrial Select Conference, on Thursday, Feb.
View more 3M to Participate in Upcoming Investor Conference analysis
Sign-up for 3M to Participate in Upcoming Investor Conference investment picks
2013/5/7
3M Unitek and Rocky Mountain Orthodontics Settle Patent Infringement Litigation
3M Unitek announced today it has successfully resolved U.S. and French patent lawsuits related to sales by RMO, Inc. (doing business as Rocky Mountain Orthodontics) of customized lingual orthodontic brackets and appliances manufactured by Lingualjet Orthodontics.
View more 3M Unitek and Rocky Mountain Orthodontics Settle Patent Infringement Litigation analysis
Sign-up for 3M Unitek and Rocky Mountain Orthodontics Settle Patent Infringement Litigation investment picks
2013/5/1
3M Unitek Introduces Revolutionary APC Flash-Free Adhesive Coated Appliance System
3M Unitek today announced its game-changing APC ™ Flash-Free Adhesive Coated Appliance System, which will be on display May 4 through May 7 during the American Association of Orthodontists (AAO) Annual 113 th Session in the 3M Unitek booth #625. The new advanced technology eliminates the flash removal step in bonding, reducing variability and saving time for orthodontists and patients.
View more 3M Unitek Introduces Revolutionary APC Flash-Free Adhesive Coated Appliance System analysis
Sign-up for 3M Unitek Introduces Revolutionary APC Flash-Free Adhesive Coated Appliance System investment picks
2013/5/2
3M Unitek Launches 3M True Definition Scanner for Orthodontic Practice
Providing a better patient experience and better oral care through digital technology, 3M Unitek today announced the availability of the 3M ™ True Definition Scanner for use in orthodontic practice—a complete digital impression system that uses 3D-in-motion video technology to deliver a true replica of the oral anatomy with precision and accuracy.
View more 3M Unitek Launches 3M True Definition Scanner for Orthodontic Practice analysis
Sign-up for 3M Unitek Launches 3M True Definition Scanner for Orthodontic Practice investment picks
2013/3/25
3M Window Film Innovation Shields Drivers and Their Valuables
According to the National Insurance Crime Bureau (NICB), an auto theft occurs every 33 seconds in the U.S. That’s roughly 1 million vehicles each year that wind up in the hands of thieves at a cost of nearly $6.4 billion.
View more 3M Window Film Innovation Shields Drivers and Their Valuables analysis
Sign-up for 3M Window Film Innovation Shields Drivers and Their Valuables investment picks
2013/5/9
3nd UPDATE: Apache Seeks to Sell $4 Billion in Oil, Gas Assets
(Updates with update Egypt production numbers in 11th paragraph) By Ben Lefebvre Apache Corp.
View more 3nd UPDATE: Apache Seeks to Sell $4 Billion in Oil, Gas Assets analysis
Sign-up for 3nd UPDATE: Apache Seeks to Sell $4 Billion in Oil, Gas Assets investment picks
2013/4/25
3Pea International, Inc. Brings State of the Art Call Center In-House
3Pea International, Inc. (OTCBB: TPNL ), a payment solutions company focused on prepaid debit card program management and processing services, today announced our new call center, a state of the art Unified Communications System which includes Phone Exchange (PBX) for call termination and origination, Interactive Voice Response (IVR), and Customer Relationship Management (CRM) features.
View more 3Pea International, Inc. Brings State of the Art Call Center In-House analysis
Sign-up for 3Pea International, Inc. Brings State of the Art Call Center In-House investment picks
2013/5/15
3Pea International, Inc. Reports Record First Quarter 2013 Results
3Pea International, Inc. (OTCBB: TPNL ), a payment solutions company focused on prepaid debit card program management and processing services, today announced record financial results for the first quarter ended March 31, 2013.
View more 3Pea International, Inc. Reports Record First Quarter 2013 Results analysis
Sign-up for 3Pea International, Inc. Reports Record First Quarter 2013 Results investment picks
2013/4/2
3Pea International, Inc. Reports Record Year End 2012 Results
3Pea International, Inc. (OTCBB: TPNL ), a leading payment solutions provider focused on prepaid debit card program management and processing services, today announced record financial results for the year ended December 31, 2012.
View more 3Pea International, Inc. Reports Record Year End 2012 Results analysis
Sign-up for 3Pea International, Inc. Reports Record Year End 2012 Results investment picks
2013/4/22
3rd UPDATE: Caterpillar First-Quarter Profit Down 45%; Sales Slump
-- Caterpillar's sales of mining equipment dropped 23% from year ago --Company slashes revenue, profit guidance for 2013 --
View more 3rd UPDATE: Caterpillar First-Quarter Profit Down 45%; Sales Slump analysis
Sign-up for 3rd UPDATE: Caterpillar First-Quarter Profit Down 45%; Sales Slump investment picks
2013/4/26
3rd UPDATE: Chevron's Earnings Drop Despite Higher Output
--Oil production down as field output declines --Natural gas prices rise --Refining outages hurt bottom line (Updates with company executive's comments) By Ben Lefebvre Chevron Corp.'s (CVX) first-quarter earnings dropped 4.5% as moderating oil prices led to a drop in revenue despite an uptick in production.
View more 3rd UPDATE: Chevron's Earnings Drop Despite Higher Output analysis
Sign-up for 3rd UPDATE: Chevron's Earnings Drop Despite Higher Output investment picks
2013/4/16
3rd UPDATE: Coke to Refranchise U.S. Bottling System; 1st-Quarter Net Off 15%
--Coca-Cola taking first steps to pass U.S. bottling operations back to independent bottlers --Drinks company discloses agreement in principle with five bottlers to take on new territory --Coca-Cola also says first-quarter earnings beat expectations as global sales volume rose 4% (Updates share price and adds comments from interview with Coca-Cola executives starting in the sixth paragraph) By Paul Ziobro Coca-Cola Co.
View more 3rd UPDATE: Coke to Refranchise U.S. Bottling System; 1st-Quarter Net Off 15% analysis
Sign-up for 3rd UPDATE: Coke to Refranchise U.S. Bottling System; 1st-Quarter Net Off 15% investment picks
2013/4/10
3rd UPDATE: ConocoPhillips Suspends 2014 Alaska Drilling Plans, Cites Regulatory Uncertainty
-- ConocoPhillips says it will revisit Alaskan drilling after regulations are clarified --
View more 3rd UPDATE: ConocoPhillips Suspends 2014 Alaska Drilling Plans, Cites Regulatory Uncertainty analysis
Sign-up for 3rd UPDATE: ConocoPhillips Suspends 2014 Alaska Drilling Plans, Cites Regulatory Uncertainty investment picks
2013/4/18
3rd UPDATE: IBM Sees Job Cuts as Profit Machine Slows
--IBM declines comment on server sale report --Company expects more job cuts than usual this quarter --Management affirms full-year target (Adds backgound on tech sector, and CFO comments.) By Drew FitzGerald International Business Machines Corp.
View more 3rd UPDATE: IBM Sees Job Cuts as Profit Machine Slows analysis
Sign-up for 3rd UPDATE: IBM Sees Job Cuts as Profit Machine Slows investment picks
2013/4/16
3rd UPDATE: J&J Sales Rise, Helped By Return of Recalled Products
--Sales get boost from Synthes acquisition --Over-the-counter products contribute to growth --Adjusted earnings and revenue top expectations (Adds details about medical device unit and J&J's observations about health-care usage trends.) By Peter Loftus Johnson & Johnson (JNJ) reported an 8.5% increase in first-quarter revenue, helped by a medical-device acquisition, higher drug sales and the return to market of some recalled over-the-counter products.
View more 3rd UPDATE: J&J Sales Rise, Helped By Return of Recalled Products analysis
Sign-up for 3rd UPDATE: J&J Sales Rise, Helped By Return of Recalled Products investment picks
2013/5/1
3rd UPDATE: MasterCard Maintains Cautious Outlook As Economic Picture Remains Cloudy
--Card-purchase volume increased 10.5% to $690 billion --Revenue of $1.91 billion missed Wall Street estimates of $1.93 billion --CEO: Not convinced U.S. consumer spending will be better in second quarter (Updates with new share price in paragraph six and CEO comment in paragraph 19.) By Andrew R.
View more 3rd UPDATE: MasterCard Maintains Cautious Outlook As Economic Picture Remains Cloudy analysis
Sign-up for 3rd UPDATE: MasterCard Maintains Cautious Outlook As Economic Picture Remains Cloudy investment picks
2013/5/8
3rd UPDATE: McDonald's, Wendy's Battle for Value-Driven Customers
-- McDonald's global same-store sales slip 0.6% in April --
View more 3rd UPDATE: McDonald's, Wendy's Battle for Value-Driven Customers analysis
Sign-up for 3rd UPDATE: McDonald's, Wendy's Battle for Value-Driven Customers investment picks
2013/5/1
3rd UPDATE: Merck 1st-Quarter Profit Down on Loss of Singulair Exclusivity
--Merck first-quarter sales disappoint, lowers 2013 outlook --Sales of diabetes drug Januvia post rare decline amid new competition --CEO says Merck will deploy more resources toward Januvia (Adds background about broader drug sector beginning in 1st paragraph; updates stock price.) By Peter Loftus Major drug makers are finding it more difficult than expected to overcome the blow of recent patent expirations, with Merck & Co.
View more 3rd UPDATE: Merck 1st-Quarter Profit Down on Loss of Singulair Exclusivity analysis
Sign-up for 3rd UPDATE: Merck 1st-Quarter Profit Down on Loss of Singulair Exclusivity investment picks
2013/4/30
3rd UPDATE: Pfizer 1st-Quarter Profit, Sales Miss Estimates as Lipitor Pressure Continues
--Pfizer first-quarter sales and earnings fall short of analysts' views on currency, other headwinds --Company still grappling with loss of exclusivity for cholesterol drug Lipitor --Pfizer reduces 2013 financial outlook (Adds comments from Pfizer CEO beginning in sixth paragraph, and details and background throughout.) By Peter Loftus Pfizer Inc. (PFE) reported a worse-than-expected 9% revenue decline for the first quarter and lowered its full-year outlook as the drug maker continues to struggle to replace billions of dollars in lost Lipitor sales.
View more 3rd UPDATE: Pfizer 1st-Quarter Profit, Sales Miss Estimates as Lipitor Pressure Continues analysis
Sign-up for 3rd UPDATE: Pfizer 1st-Quarter Profit, Sales Miss Estimates as Lipitor Pressure Continues investment picks
2013/4/18
3rd UPDATE: Verizon's 1st-Quarter Profit Jumps 16% as Wireless Margins Rise
-- Verizon reports 16% rise in first-quarter profit --Wireless service margins increase to 50.4%, highest ever --Adds 677,000 contract customers in quarter (Updates with details throughout beginning in the tenth paragraph) By Thomas Gryta Verizon Communications Inc.'s (VZ) first-quarter profit rose 16% as its wireless business continued to add customers and reached its highest profitability ever.
View more 3rd UPDATE: Verizon's 1st-Quarter Profit Jumps 16% as Wireless Margins Rise analysis
Sign-up for 3rd UPDATE: Verizon's 1st-Quarter Profit Jumps 16% as Wireless Margins Rise investment picks
2013/4/25
3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders
SHENYANG, China , April 25, 2013 /PRNewswire/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China -based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that, at the duly convened extraordinary general meeting of shareholders ("EGM") held at 10:00am Beijing time on April 25, 2013 , Dr.
View more 3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders analysis
Sign-up for 3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders investment picks
2013/3/24
3SBio Inc. Announces Extraordinary General Meeting of Shareholders
SHENYANG, China , March 24, 2013 /PRNewswire/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China -based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has called an extraordinary general meeting of shareholders (the "EGM"), to be held at 10:00 a.m. on April 25, 2013 ( Beijing time).  The meeting will be held at 15/A-D, Huaxin International Tower, No.
View more 3SBio Inc. Announces Extraordinary General Meeting of Shareholders analysis
Sign-up for 3SBio Inc. Announces Extraordinary General Meeting of Shareholders investment picks
2013/5/2
3SBio Inc. Announces Extraordinary General Meeting of Shareholders
SHENYANG, China , May 2, 2013 /PRNewswire/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China -based biotechnology company focused on researching, developing, manufacturing, and marketing biopharmaceutical products, today announced that its extraordinary general meeting of shareholders (the "EGM") that was previously adjourned on April 25, 2013 will be held on May 24, 2013 , at 10:00am , Beijing time, at the Company's offices located at 15/A-D, Huaxin International Tower, No.
View more 3SBio Inc. Announces Extraordinary General Meeting of Shareholders analysis
Sign-up for 3SBio Inc. Announces Extraordinary General Meeting of Shareholders investment picks
2013/4/22
3SBio Inc. Announces Receipt of Amended "Going Private" Proposal at $16.70 Per ADS and Intent to Adjourn Extraordinary General Meeting of Shareholders
SHENYANG, China , April 22, 2013 /PRNewswire/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China -based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the independent committee of its board of directors (the "Independent Committee") has received a proposal letter (the "Proposal Letter") dated April 22, 2013 from Dr.
View more 3SBio Inc. Announces Receipt of Amended "Going Private" Proposal at $16.70 Per ADS and Intent to Adjourn Extraordinary General Meeting of Shareholders analysis
Sign-up for 3SBio Inc. Announces Receipt of Amended "Going Private" Proposal at $16.70 Per ADS and Intent to Adjourn Extraordinary General Meeting of Shareholders investment picks
2013/3/18
3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2012 Results
2012 Q4 net revenues grew 17.2% to RMB164.0 million (US$26.3 million)) 2012 Q4 operating income decreased by 55.9% to RMB11.5 million (US$1.8 million) 2012 Q4 net income attributable to 3SBio decreased by 23.3% to RMB17.1 million (US$2.7 million) SHENYANG, China, March 18, 2013 /PRNewswire/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or  "the Company"), a leading China -based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2012 .
View more 3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2012 Results analysis
Sign-up for 3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2012 Results investment picks
2013/4/24
3SBio Inc. Enters Into Amendment to Merger Agreement For "Going Private" Transaction
SHENYANG, China, April 24, 2013 /PRNewswire/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China -based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has entered into an amendment (the "Amendment") to its previously announced agreement and plan of merger dated as of February 8, 2013 , by and among Decade Sunshine Limited ("Parent"), Decade Sunshine Merger Sub ("Merger Sub") and the Company (the "Merger Agreement", and the Merger Agreement as so amended, the "Amended Merger Agreement"), pursuant to which Merger Sub will be merged with and into the Company, with the Company surviving the merger as a wholly-owned subsidiary of Parent (the "Merger").  The Amendment follows the revised "going private" proposal from Dr.
View more 3SBio Inc. Enters Into Amendment to Merger Agreement For "Going Private" Transaction analysis
Sign-up for 3SBio Inc. Enters Into Amendment to Merger Agreement For "Going Private" Transaction investment picks
2013/5/1
3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012
SHENYANG, China , May 1, 2013 /PRNewswire/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China -based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has filed the Company's Annual Report on Form 20-F for the fiscal year ended December 31, 2012 with the U.S. Security and Exchange Commission on April 30, 2013 .
View more 3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012 analysis
Sign-up for 3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
Articles From: 3M Scientist Receives Lifetime Achievement Award for Hearing Conservation to 3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012
Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Mutual Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title
ETFs by:
Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name
Investment Categories by:
Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry
Premimum Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Premimum Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title
Premimum ETFs by:
Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name
Popular Articles by:
Title |  Date |  Author |  Collection |  Popularity |  Interest
SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Popular SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.